Vilarino-Guell et al. [35] after sequencing all DCTN1 exons and exon–intron boundaries in 286 samples diagnosed with neurodegenerative diseases (PD, FTLD, ALS) concluded that pathogenic mutations in DCTN1 are rare. This evidence concerns the gene DCTN1 and neurodegenerative disease.